---
wave: clinical-and-chemical-foundations
pulse: 05
date: 2026-07-11
status: done
depends_on: [03, 04]
governing_roles: [reference-editor, expert-skeptic, index-weaver, ascii-cartographer]
---

# Pulse 05 - Pathology Module Completion and Review

> **⇢ FINAL STATE (2026-07-12) — DONE, FINAL PASS.** This pulse began as a prototype boundary review and was
> carried through to the **full module**: all **12/12** guides are authored at full peer depth,
> source-backfilled, and reviewed. The module is **integrated**
> (`sections/life-sciences.md`, `.mkdocs/mkdocs.yml`, `TRACKER.md`),
> **reciprocally wired** with the minimal architecture-approved sibling pointers, and
> **source-corpus backfilled** (`pathology/` plus the changed siblings `disease`, `medicine`,
> `clinical-medicine`; custody `partial`; MDLOOM backfill recorded for all twelve; Git
> provenance currently recorded for 0 and pending for 12 because the guides are untracked).
> Prototype panels **R1**/**R2**, both `09`/`11` Stage-2 scaling gates, and the full-module
> adversarial panel are complete with no unresolved BLOCK/WARN. The guide-specific R2
> Gold-rubric/reader-task evidence assigns **Silver to all 12**: pathology-specific Da Vinci
> invariants are absent and external source custody remains partial, so no Gold registry rows
> were added. Those are future promotion/custody tasks, not Pulse-05 blockers.
> The final reviewer returned **PASS** with no BLOCK/WARN. **Pulse 05 is DONE.**

## Mission

Complete `pathology/` as a first-class, non-duplicating MAXIM discipline module — the
**mechanism-to-diagnosis bridge** that closes the `clinical-and-chemical-foundations` wave.
The pulse establishes the scope against sibling modules, ratifies and implements the
12-guide mechanism-to-diagnosis manifest and the three-way lab-interpretation split, applies
the four-pillar safety contract, integrates and backfills the module, and records
guide-specific adversarial and tier evidence.

> **Status: DONE — final sign-off PASS.** All 12/12 guides are authored, integrated,
> reciprocally wired, backfilled, and reviewed. Prototype R1/R2, both scaling gates,
> full-module R1, and the R2 Gold-rubric/reader-task pass are complete. There are no unresolved
> BLOCK/WARN findings. Gold promotion, Da Vinci pinning, and external-source completion remain
> future work rather than Pulse-05 exit blockers.

## Pre-implementation Scout

```powershell
# Read the governing context and exemplars
Get-Content CLAUDE.md, EXPANSION.md
Get-Content context\waves\2026-07-11-clinical-and-chemical-foundations\WAVE.md
Get-Content chemistry\STATUS.md, clinical-medicine\STATUS.md            # quality exemplars
Get-Content .claude\skills\maxim-review\SKILL.md, .claude\skills\maxim-pulse\SKILL.md
# Read the two directly-applicable gate-passed prototypes
Get-Content clinical-medicine\03-DIAGNOSTIC-TEST-INTERPRETATION.md
Get-Content clinical-medicine\08-SPECIALTY-INTERFACES.md
# Inspect the sharpest overlap surface (do NOT edit medicine/)
Get-Content medicine\10-DIAGNOSTICS-IMAGING.md                          # the catalog owner
# Read the clinical architecture record's pathology coordination (MAXIM-CLIN-12)
Get-Content context\waves\2026-07-11-clinical-and-chemical-foundations\artifacts\CLINICAL-MEDICINE-ARCHITECTURE.md
```

## Scope Inventory

| Area | Files |
|---|---|
| Prototype guides | `pathology/08-LABORATORY-MEDICINE.md`, `pathology/10-DIAGNOSIS-PATTERN-RECOGNITION-AND-REPORTING.md` |
| Module manifest | `pathology/STATUS.md` (full 12-guide manifest; **12/12 authored / reviewed**; module complete) |
| Architecture record | `context/waves/.../artifacts/PATHOLOGY-ARCHITECTURE.md` (MAXIM-PATH-01 … 25 + G00 … G11) |
| Wave tracking | `context/waves/.../pulses/05+pathology-architecture.md`; `WAVE.md` pulses table (Pulse 05 → DONE — FINAL PASS) |
| **Completed 2026-07-12 (was "Deferred post-sign-off")** | `00-OVERVIEW` + guides 01–07, 09, 11 authored; reciprocal `clinical-medicine/03`→`pathology/` and `medicine/10`→`pathology/08` cross-references added (plus `disease/00`→`01`–`03`, `disease/04`→`05`/`10`); `sections/life-sciences.md`, `.mkdocs/mkdocs.yml`, `TRACKER.md` wired; source-corpus regenerated (`.mdloom/backfill/**`, `.crop/**`, `.mdport/**`, `.fletch/**`) |

## Scope Contract (non-duplication)

- **Uniquely owns** the mechanism-to-diagnosis bridge: general-pathology mechanisms
  (cell injury; inflammation/repair; hemodynamics; immunopathology-as-injury; neoplasia;
  genetic/developmental/metabolic; environmental/nutritional/toxic), **laboratory-result
  generation and bounding** (08), anatomic technique as principle (09), **morphology-to-
  diagnosis reasoning and the report** (10), and the diagnostic laboratory as a quality
  system (11) — organized around **mechanism and reusable diagnostic method, not per-organ
  systemic pathology** (MAXIM-PATH-18), mirroring chemistry's "split by problem, not
  technique" and clinical-medicine's "reusable patterns, not per-organ specialties."
- **Defers** disease entities/catalogs/natural history and entity-specific grading/staging
  systems to `disease/`; anatomy/physiology to `human-biology/`; the diagnostics/imaging
  **catalog** and reference ranges to `medicine/10`; **Bayesian belief updating** to
  `clinical-medicine/03`; the *clinical* differential + bias cognition to
  `clinical-medicine/02`; immune-cell biology to `immunology/`; organism biology to
  `microbiology/`/`virology/`; gene/pathway mechanism to `genomics/`/`biochemistry/`; the
  general analytical formalism to `chemistry/04`; and forensic/legal determination to
  `law/`/`criminology/` (out of scope).
- **Three-way lab-interpretation split (ratified this pulse, MAXIM-PATH-06):**
  `pathology/08` (why/how the result is and how far to trust it) → `medicine/10` (the
  catalog & reference bands) → `clinical-medicine/03` (how a clinician updates belief and
  decides to act). This ratifies the coordination `clinical-medicine` Pulse 03
  (MAXIM-CLIN-12) explicitly deferred to pathology authoring.
- **Four-pillar non-advice / non-procedure contract** is a hard gate: (1) no self-diagnosis
  / no personal-result or personal-slide interpretation; (2) no specimen-collection or
  laboratory-operating instructions; (3) no forensic/legal advice; (4) third-person
  descriptive voice with illustrative, dated numbers. Any imperative-mood interpretation,
  bench/collection procedure, or forensic/legal determination is a **BLOCK**.

## Deliverables

- [x] Architecture record with research question, findings MAXIM-PATH-01 … 25, the ratified
      12-guide manifest (G00 … G11), ownership/defer contract, **four-pillar** safety
      contract, bias/limitations, quality risks, and adopt/prototype/defer decisions
      (`artifacts/PATHOLOGY-ARCHITECTURE.md`).
- [x] R1/R2 prototype adversarial review completed under
      `panels/pathology-prototype-r1/` and `panels/pathology-prototype-r2/`; all
      prototype BLOCK/WARN findings repaired.
- [x] `pathology/STATUS.md` — full 12-guide manifest at **12/12 authored / reviewed**;
      authored/integrated/backfilled state, boundary contracts, Silver tier decision,
      source-custody limits, and four-pillar contract recorded.
- [x] `08-LABORATORY-MEDICINE.md` — total testing process (brain-to-brain loop); result as
      a manufactured product with a tolerance; measurand/traceability/standardization;
      imprecision/bias/total error/measurement uncertainty/sigma; linearity/AMR/LoB-LoD-LoQ;
      **analytical vs clinical Sn/Sp** (the central confusion); interference (HIL,
      heterophile, biotin, macro-analyte, hook); method comparison/harmonization (Deming/
      Passing–Bablok/Bland–Altman, RCV/delta checks); how each discipline manufactures a
      result (chemistry, hematology + the **cell-counting/smear-morphology interface**,
      coagulation, microbiology, molecular, the transfusion interface); validation/
      autoverification/flags/critical values. Owns the *result*; defers the catalog to
      `medicine/10` and belief-update to `clinical-medicine/03`; four-pillar banner;
      ownership header; landscape; systems bridges; 5 reader tasks; Decision Cheat Sheet;
      Common Confusion Points; resource/geographic/bias caveats.
- [x] `10-DIAGNOSIS-PATTERN-RECOGNITION-AND-REPORTING.md` — diagnosis as an inference
      pipeline; morphology as a parse (architecture/cytology/context); pattern-before-
      diagnosis; the two-axis differential; **differential pattern classes** (reusable
      taxonomy, multi-organ examples for method not catalog); **ancillary tests as
      conditional-probability evidence** (a stain is a test with Sn/Sp; panels/controls/
      decisive-vs-supportive); the **certainty ladder** (calibrated uncertainty language);
      **grade ⟂ stage ⟂ margin** principles + reproducibility limits; the **report as an
      interface** (synoptic vs narrative); **critical-diagnosis** verified-delivery loop;
      **amendment vs addendum vs retraction**; a fully **fictional end-to-end specimen-to-
      signed-report case**; **resource-tier variation**. Teaches a reusable method; defers
      entities to `disease/` and belief-update to `clinical-medicine/03`; four-pillar
      banner; ownership header; landscape; systems bridges; 5 reader tasks; Decision Cheat
      Sheet; Common Confusion Points; resource/geographic/bias caveats.
- [x] `WAVE.md` pulses table updated — Pulse 05 → **DONE — FINAL PASS**.
- [x] **Prototype review (gate) — round R1 run and repaired:** adversarial `expert-skeptic`
      (advice-/procedure-creep + quantitative-honesty) + `reference-editor` panel over
      `08`/`10`, recorded under `panels/pathology-prototype-r1/` (expert-skeptic,
      reference-editor, consolidated). R1's findings are **repaired** in `08`/`10`, the
      architecture record, and `STATUS.md`. This gate passed and enabled full
      authoring/integration.
- [x] **Prototype review (gate) — strict re-review round R2 run and repaired:** a second
      adversarial `expert-skeptic` + `reference-editor` pass over `08`/`10`, recorded under
      `panels/pathology-prototype-r2/`, closing the remaining finer-grained findings —
      matched-unit total-error formulas (`TEcalc_abs`/`TEcalc_%`) + percentage sigma with a
      stated one-sided-z convention; **RCV reserved for serial within-person change** on the
      same/comparable method (cross-lab RCV recommendation removed in favor of method
      bias/uncertainty/commutability/traceability/method-comparison); **spectrum-dependent
      Sn/Sp/LR split from prevalence-dependent PPV/NPV/posterior** (posterior deferred to
      `clinical-medicine/03`); **margin** wording corrected to examined-inked-margin status
      (**not proof of complete excision**); the thyroid-FNA
      tissue-architecture-vs-cytologic-group-arrangement distinction; the **expanded
      two-stage `09`/`11` scaling gate**; and **truthful prototype frontmatter**
      (`status: prototype` / `source_custody: needs-source` / `backsource_ids: []`,
      MAXIM-PATH-25). Repaired in `08`/`10`, the architecture record, and `STATUS.md`.
      This strict prototype gate passed and enabled the scaling/full-module rounds.
- [x] **Scaling-gate authoring and review — guides 09 and 11 authored at full depth:**
      under the MAXIM-PATH-24 scaling mini-contracts, `09-ANATOMIC-PATHOLOGY-TECHNIQUE.md` and
      `11-QUALITY-ERROR-AND-THE-DIAGNOSTIC-LABORATORY-AS-SYSTEM.md` are authored at full peer
      depth and focused-MDLOOM-clean, with their Stage-1 high-risk surfaces covered in-guide and
      **Stage-2 whole-procedure/whole-seam reviews complete and PASS** after repair (see the
      *Scaling-Gate* section and completed panel records under
      `panels/pathology-09-scaling/` and `panels/pathology-11-scaling/`).
- [x] **Full authoring + integration round (this addendum):** authored `00-OVERVIEW` and the
      seven mechanism guides `01`–`07` at full MAXIM peer depth (four-pillar banner,
      ownership/defer header, landscape diagram, layered molecular→cellular→tissue formalism,
      worked fictional cases, decision-useful tables, systems bridges, 3–5 solved reader tasks,
      Decision Cheat Sheet, Common Confusion Points, resource/geographic/bias caveats), all
      focused-MDLOOM-clean (`0 errors, 0 warnings`) with **0** second-person voice and hard
      defers to `disease/`/`immunology/`/`genomics/`/`microbiology/`. **Integrated** the module
      into `sections/life-sciences.md` (Directories row + count), `.mkdocs/mkdocs.yml`
      (`Pathology: pathology/00-OVERVIEW.md`), and `TRACKER.md` (dashboard row + wave line + a
      `✅ Complete` dashboard row; the generic `🔬 In review` legend remains available for
      future work). Added the **architecture-approved minimal reciprocal
      sibling pointers**: `disease/00-OVERVIEW` → pathology fundamentals `01`–`03`;
      `disease/04-CANCER` → tumor grading/pTNM/IHC depth `05`/`10`;
      `medicine/10-DIAGNOSTICS-IMAGING` → lab-result generation `08` (preserving its
      `clinical-medicine/03` decision-theory pointer); and made the `clinical-medicine/03`
      forward pointer accurate (removed the stale "(planned)"). Ran **source-corpus backfill**
      (`--module-id pathology`) and re-backfilled every sibling module whose canonical guide
      changed (`disease`, `medicine`, `clinical-medicine`); guide frontmatter promoted to
      `source_custody: partial`. No sibling module otherwise rewritten.
- [x] **Full-module review and tier evidence:** full-module `expert-skeptic` +
      `reference-editor` panel completed; all findings repaired; guide `11` clean review
      folded in; per-guide ten-dimension Gold rubric and reader tasks recorded in
      `panels/pathology-full-r1/R2-gold-rubric.md`; Silver assigned to all twelve; no registry
      insertion.
- [ ] **Remaining before sign-off / wave close:** final Pulse-05 sign-off only. Gold/Da Vinci
      promotion and external-source completion are future work and do not block this wave's
      own exit gate. No commit/push in this round.

## Scaling-Gate — Guides 09 and 11 (both Stage-2 PASS)

Per MAXIM-PATH-24 and the architecture record's *Scaling Mini-Contracts* section, the two
scaling-risk guides were authored and reviewed **under their mini-contracts** before the
full-module closeout. Both meet the full MAXIM peer-depth bar
(ownership/defer header, four-pillar banner, landscape, layered formalism, representative
high-risk worked fictional cases, decision tables, systems bridges, reader tasks, Decision
Cheat Sheet, Common Confusion Points, resource/bias caveats) and have passed their
guide-level gates.

- **`09-ANATOMIC-PATHOLOGY-TECHNIQUE.md` — substrate technique as purpose/failure-mode only.**
  Every gross-to-glass step (grossing/orientation/sampling, fixation, processing/embedding/
  microtomy, H&E and special stains, IHC substrate, cytology preparation, frozen section,
  molecular/digital substrate) is written strictly as *purpose → failure mode → downstream
  consequence* with the pillar-2 hard exclusion enforced: **no reagent formulations, times,
  temperatures, dilutions, cutting sequences, or block counts, and no imperative bench step.**
  Cross-references resolve substrate → `10 §4` (analytical validity / Gate 1) and → `08`
  (molecular/IHC signal generation). *Stage-1* representative high-risk surfaces —
  grossing/orientation plus staining, frozen section, and cytology preparation — are covered
  within the no-SOP boundary. **Stage-2: the completed-guide whole-procedure `expert-skeptic`
  review over the entire gross-to-glass surface has been run and **PASSES (2026-07-12)** — zero
  runnable steps end to end; guide 09's per-guide gate is cleared (recorded in
  `panels/pathology-09-scaling/`).**
- **`11-QUALITY-ERROR-AND-THE-DIAGNOSTIC-LABORATORY-AS-SYSTEM.md` — the cross-process quality
  system.** Owns QC/QA/EQA as a layered control program, the phase-indexed cross-process error
  taxonomy, validation/verification and document/change-control **governance**, accreditation/
  competence **as concepts** (dated, attributed, non-prescriptive — no accreditation how-to or
  jurisdiction-specific compliance steps), incident/CAPA/amendment loops, turnaround/
  traceability, the conceptual autopsy/audit boundary (forensic cause/manner-of-death **out of
  scope**, pillar 3), and system resilience. The **`08`↔`11` seam** is explicit and one-way
  clean — `08` owns per-result metrology and only the local QC needed to bound one result;
  `11` owns the cross-process program and **re-derives none of `08`'s metrology** — and the
  general clinical system-safety science (Swiss-cheese, just culture, RCA, HRO, Donabedian,
  PDSA) is **deferred to `clinical-medicine/11`**. *Stage-1* representative high-risk surfaces
  — governance/accreditation plus the total-testing-process `08`↔`11` error-taxonomy/QC seam —
  are covered in-guide. **Stage-2: the completed-guide whole-seam `expert-skeptic` review has
  been run (2026-07-12) and returned seam/accuracy findings — the `08`↔`11` EQA/PT seam (no
  re-derivation of `08 §6`; IQC detects *some* bias; EQA is a comparison, not an oracle, and
  ⊋ PT), QC chart semantics (Levey–Jennings limits from the control's own mean/SD; `1_2s`
  warning vs `1_3s`/multirule; bias/TEa/sigma inform QC planning; non-chemistry controls),
  CAPA (correction vs corrective action vs preventive/risk control), accreditation (ISO
  15189:2022 competence/impartiality/consistent-operation, not certification), validation/
  verification depth, nonconforming-work/amendment stratification, audit-instrument and
  traceability-vs-legal-chain-of-custody distinctions, and a resource-constrained case/task.
  All findings are **repaired in the guide**; the clean whole-seam review is complete and
  guide 11 **PASSES** (recorded in `panels/pathology-11-scaling/`).**

**Two-stage gate status: Stage-1 satisfied in-guide; Stage-2 run (2026-07-12) — `09` PASS,
`11` PASS after repair.** The Stage-2 adversarial `expert-skeptic`
reviews are recorded under `panels/pathology-09-scaling/` (PASS) and
`panels/pathology-11-scaling/` (PASS after repair). Both per-guide gates are cleared.

## Validation

Focused prototype validation only (per the boundary-review scope; **no full-module source
backfill**) — **[SUPERSEDED 2026-07-12: full-module validation has since been run; see
"Full-module validation (2026-07-12)" at the end of this section.]**:

```powershell
# Repo-config MDLOOM (MAXIM mdloom.toml) via the tools-infra/proof Cargo manifest,
# scoped to the two prototype guides
cargo run --manifest-path C:\src\TRACKER\repos\tools-infra\proof\Cargo.toml -- `
  check pathology\08-LABORATORY-MEDICINE.md `
        pathology\10-DIAGNOSIS-PATTERN-RECOGNITION-AND-REPORTING.md --config mdloom.toml
git --no-pager diff --check
```

If the Cargo-manifest MDLOOM is unavailable in the environment, record the exact failure
and fall back to focused structural validation (single H1; required `## Decision Cheat
Sheet` H2; ≥1 code block; no `@editor` tags; aligned ASCII boxes; consistent tables) plus
`git diff --check`, per `.claude/skills/maxim-pulse/SKILL.md`.

Each prototype guide carries a landscape diagram, a layered model with the actual
formalism (metrology math — imprecision/bias, **calculated vs allowable total error**,
measurement uncertainty, and the **relative-change RCV** — in `08`; the inference
pipeline, the **multidimensional parse matrix**, the **four independent certainty
dimensions** on locally governed lexicons, and orthogonal grade/stage/margin axes in `10`),
decision-useful tables, explicit ownership/cross-reference boundaries, 5 reader tasks, a
Decision Cheat Sheet, and Common Confusion Points. Numeric specifics are labeled
illustrative; framework attributions (brain-to-brain loop; GUM/ISO uncertainty; CLSI
EP17/AUTO10-A→AUTO15; UICC/AJCC TNM elements-vs-stage-group; CAP/ICCR/RCPath synoptic) are
named, **qualified as grounded in standard summaries (not authoritative)**, and to be
re-verified against primary sources during full authoring (see MAXIM-PATH-23).

**Validation outcome (R1 and R2 repair rounds):** the focused Cargo MDLOOM, re-run after the
R1 and then the strict-R2 repairs to `08`/`10`, reports **2 files checked, 0 errors, 0
warnings**, and `git diff --check` is clean (the pathology module is untracked, so the MDLOOM
check was run against the two prototype guides explicitly). Source backfill was **not** run,
and `medicine/`, `clinical-medicine/`, `sections/`, `.mkdocs/`, and `TRACKER.md` were **not**
touched.

**Scaling-gate validation (guides 09 and 11).** The same focused Cargo MDLOOM, scoped to the
two scaling-gate guides, was run after authoring:

```powershell
cargo run --release --manifest-path C:\src\TRACKER\repos\tools-infra\proof\Cargo.toml -- `
  check pathology\09-ANATOMIC-PATHOLOGY-TECHNIQUE.md `
        pathology\11-QUALITY-ERROR-AND-THE-DIAGNOSTIC-LABORATORY-AS-SYSTEM.md --config mdloom.toml
git --no-pager diff --check
```

Outcome: **2 files checked, 0 errors, 0 warnings**; `git diff --check` clean. Structural
spot-check on each: single H1, landscape diagram, required `## Decision Cheat Sheet`, balanced
code fences, no `@editor` tags, and **0** `you/your` (four-pillar third-person voice). Both
guides carry the actual formalism (`09`: the gross-to-glass lossy-compile pipeline as
*purpose → failure mode → downstream consequence*, with the pillar-2 no-runnable-steps
boundary; `11`: the total-testing-process quality-control loop, the phase-indexed error
taxonomy, and the explicit `08`↔`11` seam), decision tables, systems bridges, worked fictional
cases, reader tasks, and resource/bias caveats. Frontmatter is at the truthful pre-backfill
state (`status: prototype`, `source_custody: needs-source`, `backsource_ids: []`). The focused
Cargo MDLOOM was **re-run after the Stage-2 whole-seam repairs to `11`** and again reports **2
files checked, 0 errors, 0 warnings** with `git diff --check` clean. **Stage-2 whole-guide
reviews are now run**: `09` **PASS** and `11` **PASS after repair** (recorded under
`panels/pathology-09-scaling/` and `panels/pathology-11-scaling/`). This paragraph records the
historical scaling-round validation; the full-module backfill/integration result is below.

**Full-module validation (2026-07-12; authoring/integration + conservative full-module review).**
After authoring `00`–`07`, integrating, wiring the reciprocal pointers, and repairing the
conservative full-module review findings (guide 09 imperative recasts + cytology substrate +
small-biopsy qualifier; guide 05 epithelial-scoped basement-membrane definition; guide 07
non-ionizing UV-vs-thermal split; guide 08 measurand-vs-procedure separation; the stale
"planned guide 11" references in 08/10; and the guide 00 navigation case + reader tasks),
validation was re-run at module scope:

```powershell
# Source-corpus backfill + validation for pathology and every changed sibling
python .claude\skills\maxim-source-backfill\scripts\module_source_backfill.py --module-dir pathology         --module-id pathology         --validate
python .claude\skills\maxim-source-backfill\scripts\module_source_backfill.py --module-dir disease           --module-id disease           --validate
python .claude\skills\maxim-source-backfill\scripts\module_source_backfill.py --module-dir medicine          --module-id medicine          --validate
python .claude\skills\maxim-source-backfill\scripts\module_source_backfill.py --module-dir clinical-medicine --module-id clinical-medicine --validate
# Focused MDLOOM over all twelve pathology guides
$pathologyGuides = Get-ChildItem pathology -File -Filter "??-*.md" | ForEach-Object FullName
cargo run --manifest-path C:\src\TRACKER\repos\tools-infra\proof\Cargo.toml -- check $pathologyGuides --config mdloom.toml
# Backfill-generator unit tests (git-history custody behavior)
python -m unittest discover -s .claude\skills\maxim-source-backfill\tests -p "test_*.py"
git --no-pager diff --check
```

Outcome: **pathology 12/12 guides round-trip PASS, 0 errors, 0 warnings** on focused MDLOOM;
disease 11/11, medicine 11/11, clinical-medicine 12/12 — all with `finding_count: 0` on the
FLETCH registry validation and a clean CROP view-store inspect. The **backfill-generator
custody fix** (record a `git-history` backsource only when the file has real tracked history)
is covered by focused unit tests (tracked-history-present vs untracked/no-history), which pass.
Because `pathology/` and `clinical-medicine/` are still untracked, their regenerated
guide/source-record backsources carry `mdloom-backfill` only and each source-record's Git
provenance stays `pending`; the tracked siblings `disease`/`medicine` correctly retain their
`git-history` backsources. `git diff --check` is clean.

## Status

Architecture ratified and recorded; the three-way lab split ratified (MAXIM-PATH-06); the
two highest-risk boundary guides authored at full depth and focused-MDLOOM-clean;
`STATUS.md` manifest and wave tracking updated. The adversarial prototype gate
(`expert-skeptic` advice-/procedure-creep + `reference-editor`) has been run as **round R1**
and a strict re-review **round R2**, with findings repaired in `08`/`10`, the architecture
record, and `STATUS.md`, recorded under `panels/pathology-prototype-r1/` and
`panels/pathology-prototype-r2/`. R2 closed the remaining finer-grained findings (matched-unit
total error + percentage sigma; RCV reserved for serial within-person change; the
spectrum-vs-prevalence Sn/Sp/LR–PPV/NPV split; examined-inked-margin wording; the FNA
architecture-vs-cytologic-group distinction; the two-stage `09`/`11` scaling gate; truthful
prototype frontmatter). The **Stage-2 scaling reviews have since been run (2026-07-12)**: guide `09` **PASSES** its
whole-procedure review, and guide `11` **PASSES** its whole-seam review after the recorded
repairs (see `panels/pathology-09-scaling/` and `panels/pathology-11-scaling/`).

**Authoring + integration round (this addendum).** Following the boundary/scaling gates, the
remaining guides have now been **authored** — `00-OVERVIEW` and the seven mechanism guides
`01`–`07` — at full peer depth and focused-MDLOOM-clean, completing all **12/12** guides. The
module has been **integrated** (`sections/life-sciences.md`, `.mkdocs/mkdocs.yml`, `TRACKER.md`),
**reciprocally wired** with the architecture-approved minimal sibling pointers
(`disease/00`→`01`–`03`; `disease/04`→`05`/`10`; `medicine/10`→`08` preserving the
`clinical-medicine/03` pointer; `clinical-medicine/03`→`pathology/` made accurate), and
**source-backfilled** (`pathology/` plus the changed siblings `disease`, `medicine`,
`clinical-medicine`), with frontmatter promoted to `source_custody: partial`.

**Final sign-off (2026-07-12): PASS. Pulse 05 is DONE.** Authoring, integration,
reciprocal wiring, source-corpus regeneration, both scaling gates, full-module adversarial
review, and the R2 Gold-rubric/reader-task review are complete with no unresolved
BLOCK/WARN. All twelve guides are Silver; Da Vinci, Gold promotion, and stronger external
source custody remain optional future work. No commit/push was performed in this round.

## Non-Goals

- Do not expand into per-organ systemic-pathology guides or duplicate sibling catalogs.
- Do not modify `README.md`, `FOREWORD.md`, `VOLUMES.md`, `PROJECTS.md`, or any unrelated
  module.
- Do not lower the depth bar to introductory-textbook prose or template filling.
- Do not add self-diagnosis, personal-result/slide interpretation, specimen-collection or
  bench procedures, or forensic/legal determinations (four-pillar contract).
